The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2016

Filed:

Mar. 13, 2012
Applicants:

Keith Foster, Salisbury, GB;

John Chaddock, Salisbury, GB;

Philip Marks, Abingdon, GB;

Patrick Stancombe, Salisbury, GB;

Kei Roger Aoki, Irvine, CA (US);

Joseph Francis, Irvine, CA (US);

Lance Steward, Irvine, CA (US);

Inventors:

Keith Foster, Salisbury, GB;

John Chaddock, Salisbury, GB;

Philip Marks, Abingdon, GB;

Patrick Stancombe, Salisbury, GB;

Kei Roger Aoki, Irvine, CA (US);

Joseph Francis, Irvine, CA (US);

Lance Steward, Irvine, CA (US);

Assignees:

Allergan, Inc., Irvine, CA (US);

Ipsen Bioinnovation Limited, Abingdon, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C12N 9/52 (2006.01); C12N 15/62 (2006.01); C07K 14/665 (2006.01);
U.S. Cl.
CPC ...
C12Y 304/24069 (2013.01); C07K 14/665 (2013.01); C12N 9/52 (2013.01); C12N 15/62 (2013.01); A61K 38/00 (2013.01); C07K 2319/055 (2013.01);
Abstract

A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment can cleave a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a Targeting Moiety that can bind to a Binding Site on the nociceptive sensory afferent, which Binding Site can undergo endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, which is located between the non-cytotoxic protease and the Targeting Moiety; and a translocation domain that can translocate the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent; wherein the Targeting Moiety is BAM, β-endorphin, bradykinin, substance P, dynorphin and/or nociceptin. Nucleic acid sequences encoding the fusion proteins, methods of preparing same and uses thereof are also described.


Find Patent Forward Citations

Loading…